Similar articles

• Melanoma: do we need a hatchet or a scalpel?

  Shackleton MJ, Quintana E, Fullen DR, Sabel MS, Johnson TM. Shackleton MJ, et al. Arch Dermatol. 2009 Mar;145(3):307-8. doi: 10.1001/archdermatol.2009.3. Arch Dermatol. 2009. PMID: 19289763 No abstract available.
• Human malignant melanoma harbours a large fraction of highly clonogenic cells that do not express markers associated with cancer stem cells.

  Prasmickaite L, Skrbo N, Høifødt HK, Suo Z, Engebråten O, Gullestad HP, Aamdal S, Fodstad Ø, Maelandsmo GM. Prasmickaite L, et al. Pigment Cell Melanoma Res. 2010 Jun;23(3):449-51. doi: 10.1111/j.1755-148X.2010.00690.x. Epub 2010 Mar 13. Pigment Cell Melanoma Res. 2010. PMID: 20236249 No abstract available.
• Molecular markers of melanocytic tumor progression.

  Weterman MA, van Muijen GN, Bloemers HP, Ruiter DJ. Weterman MA, et al. Lab Invest. 1994 May;70(5):593-608. Lab Invest. 1994. PMID: 8196357 Review. No abstract available.
• Spheres of influence in cancer stem cell biology.

  Perego M, Alison MR, Mariani L, Rivoltini L, Castelli C. Perego M, et al. J Invest Dermatol. 2011 Feb;131(2):546-7. doi: 10.1038/jid.2010.305. Epub 2010 Oct 21. J Invest Dermatol. 2011. PMID: 20962857 No abstract available.
• Melanoma stem cells.

  Roesch A. Roesch A. J Dtsch Dermatol Ges. 2015 Feb;13(2):118-24. doi: 10.1111/ddg.12584. J Dtsch Dermatol Ges. 2015. PMID: 25631128 Review. English, German.